Barbara Weber is the founder of Tango Therapeutics. Tango Therapeutics has raised $55M in total funding. Latest round: Series A. Based in Boston, USA.
Barbara Weber, MD, is the Chief Executive Officer and a co-founder of Tango Therapeutics, a Boston-based biotechnology company. She served as interim CEO when the company launched in March 2017 with a $55 million Series A from Third Rock Ventures. Weber was also elected to the supervisory board of ITM Radiopharma.
Full founder directory · Investor directory · Company funding database · Fundraising library